Clinical Trial Update: Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis [Phase 1]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 1 pilot study evaluating budesonide in patients with primary sclerosing cholangitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sclerosing Cholangitis

Drugs mentioned

• Budesonide (BUDESONIDE)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Cholangitis, Sclerosing, Liver Cirrhosis, Biliary | Phase 1 | Status: COMPLETED